(Q36688935)

15 August 2017

1 reference

title

First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapy (English)

1 reference

15 August 2017

Luis M Schang

1 reference

15 August 2017

language of work or name

1 reference

1 December 2006

1 reference

Expert Review of Anti-infective Therapy

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

953-956

1 reference

Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Imatinib-induced regression of AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Cyclin-dependent kinases as cellular targets for antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Herpes simplex viruses in antiviral drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.953

21 January 2018

Identifiers

DOI

10.1586/14787210.4.6.953

1 reference

15 August 2017

1 reference